|
9,9-螺二氟-4-基-二苯基氧化膦
|
S290056-1g
|
升华级, ≥99%(HPLC) |
1314243-72-5 |
1g
|
¥ 11897.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2,2'':7'',2''''-三联-9,9'-螺双[9H-芴]
|
S289985-1g
|
≥99% |
518997-91-6 |
1g
|
¥ 1969.9
|
现货 |
|
0 |
阿拉丁 |
|
2-(9,9-螺二芴-2-基)-9,9-螺二芴
|
S289984-1g
|
升华级, ≥99%(HPLC) |
664345-18-0 |
1g
|
¥ 8407.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
SR 202,PPARγ拮抗剂
|
S288929-50mg
|
≥98% |
76541-72-5 |
50mg
|
¥ 534.9
|
现货 |
|
0 |
阿拉丁 |
|
SR 202,PPARγ拮抗剂
|
S288929-10mg
|
≥98% |
76541-72-5 |
10mg
|
¥ 291.9
|
现货 |
|
0 |
阿拉丁 |
|
(S)-锌 3573,ZINC 3573的阴性对照
|
S288927-5mg
|
≥98%(HPLC) |
2095596-11-3 |
5mg
|
¥ 750.9
|
现货 |
|
0 |
阿拉丁 |
|
(S)-锌 3573,ZINC 3573的阴性对照
|
S288927-25mg
|
≥98%(HPLC) |
2095596-11-3 |
25mg
|
¥ 2422.9
|
现货 |
|
0 |
阿拉丁 |
|
SR 9243,LXR反向激动剂
|
S288886-50mg
|
≥98% |
1613028-81-1 |
50mg
|
¥ 326.9
|
现货 |
|
0 |
阿拉丁 |
|
SR 9243,LXR反向激动剂
|
S288886-10mg
|
≥98% |
1613028-81-1 |
10mg
|
¥ 183.9
|
现货 |
|
0 |
阿拉丁 |
|
SAR 216471 盐酸盐
|
S288883-10mg
|
≥98%(HPLC) |
1279829-64-9 |
10mg
|
¥ 2514.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
SR 16832,双位PPARγ抑制剂
|
S288882-5mg
|
≥98%(HPLC) |
2088135-12-8 |
5mg
|
¥ 555.9
|
现货 |
|
0 |
阿拉丁 |
|
SR 16832,双位PPARγ抑制剂
|
S288882-25mg
|
≥98%(HPLC) |
2088135-12-8 |
25mg
|
¥ 2085.9
|
现货 |
|
0 |
阿拉丁 |
|
Santacruzamate A,HDAC2抑制剂
|
S288868-50mg
|
Moligand™, ≥98%(HPLC) |
1477949-42-0 |
50mg
|
¥ 1015.9
|
现货 |
|
0 |
阿拉丁 |
|
Santacruzamate A,HDAC2抑制剂
|
S288868-10mg
|
Moligand™, ≥98%(HPLC) |
1477949-42-0 |
10mg
|
¥ 243.9
|
现货 |
|
0 |
阿拉丁 |
|
SB 243213 二盐酸盐
|
S288863-50mg
|
≥99%(HPLC) |
1780372-25-9 |
50mg
|
¥ 6649.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
SB 243213 二盐酸盐
|
S288863-10mg
|
≥99%(HPLC) |
1780372-25-9 |
10mg
|
¥ 1709.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
SPT Imidazopyridine 1,丝氨酸棕榈酰转移酶抑制剂
|
S288862-50mg
|
≥98% |
1933533-18-6 |
50mg
|
¥ 8999.9
|
现货 |
|
0 |
阿拉丁 |
|
SPT Imidazopyridine 1,丝氨酸棕榈酰转移酶抑制剂
|
S288862-10mg
|
≥98% |
1933533-18-6 |
10mg
|
¥ 3699.9
|
现货 |
|
0 |
阿拉丁 |
|
SR 10067,Rev-Erbα/β激动剂
|
S288821-50mg
|
≥98%(HPLC) |
1380548-02-6 |
50mg
|
¥ 11679.9
|
现货 |
|
0 |
阿拉丁 |
|
SR 10067,Rev-Erbα/β激动剂
|
S288821-10mg
|
≥98%(HPLC) |
1380548-02-6 |
10mg
|
¥ 3499.9
|
现货 |
|
0 |
阿拉丁 |
|
2,3-二氢-N,N-二甲基-2-氧代-3-[(4,5,6,7-四氢-1H-吲哚-2-基)亚甲基] -1H-吲哚-5-磺酰胺
|
S288813-5mg
|
Moligand™, ≥97% |
330161-87-0 |
5mg
|
¥ 346.9
|
现货 |
|
0 |
阿拉丁 |
|
2,3-二氢-N,N-二甲基-2-氧代-3-[(4,5,6,7-四氢-1H-吲哚-2-基)亚甲基] -1H-吲哚-5-磺酰胺
|
S288813-25mg
|
Moligand™, ≥97% |
330161-87-0 |
25mg
|
¥ 1389.9
|
现货 |
|
0 |
阿拉丁 |
|
SR 16584,α3β4nAChR拮抗剂
|
S288804-50mg
|
≥98% |
1150153-86-8 |
50mg
|
¥ 9621.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
SR 16584,α3β4nAChR拮抗剂
|
S288804-10mg
|
≥98% |
1150153-86-8 |
10mg
|
¥ 2297.9
|
期货,请咨询 |
|
0 |
阿拉丁 |